gG-2p20 [3650]



gG-2p20


SMILES CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C
InChIKey KKWBTFWTAVUNSC-NMUKIVKQSA-N
Sequence GLLWVEVGGEGPGPT
HELM PEPTIDE1{G.L.L.W.V.E.V.G.G.E.G.P.G.P.T}$$$$

Chemical Properties

Hydrogen bond acceptors 19
Hydrogen bond donors 18
Rotatable bonds 42
Log P -4.406
Molecular weight (Da) 1466.7
Stereochemistry info partial

Database connections

Model (AF2) FPR1


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

gG-2p20


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) FPR1


Compound is not listed as a drug.